查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593036

靜脈輸液幫浦市場：依產品、依適應症分類 - 全球預測 2025-2030 年

Intravenous Infusion Pump Market by Product (Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps), Disease Indication (Analgesia or Pain Management, Chemotherapy, Diabetes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年靜脈輸液幫浦市場價值為44.4億美元，預計2024年將達到48.5億美元，複合年成長率為9.85%，預計到2030年將達到85.7億美元。

靜脈 (IV) 輸液幫浦是重要的醫療設備，旨在將受管制量的液體（例如營養物質和藥物）直接輸送到患者的血液中。這項需求源自於精確管理靜脈輸液的需要，特別是在重症患者的醫療環境中，以確保最佳的治療結果和病患安全。廣泛應用於醫院、門診、居家醫療等醫療機構。最終用途應用涵蓋腫瘤學、胃腸病學、小兒科和疼痛管理等不同的醫療領域，其中精確的液體管理至關重要。慢性病盛行率的增加、老年人口的增加以及醫療設備的技術進步是推動輸液幫浦市場的主要成長要素。該市場最新的潛在機會在於雲端運算和物聯網等智慧技術的融合，從而增強資料分析和遠端監控能力。為了抓住這些機遇，企業應專注於與高科技公司的共同創新，加強研發力度，並加強監管合規性。然而，先進泵浦的高成本、嚴格的監管要求以及技術故障風險等限制對市場成長構成了重大挑戰。此外，需要訓練有素的醫療保健專業人員來操作這些設備並確保患者安全也可能阻礙市場擴張。創新領域包括開發具有先進安全功能的經濟高效的輸液泵、提高無線通訊能力以及增強用戶介面設計以減少人為錯誤。此外，在不影響功能的情況下探索設備小型化以提高便攜性也可能推動市場成長。輸液幫浦市場是一個競爭激烈的市場，其特點是不斷的技術進步和嚴格的法律規範，需要不斷創新才能跟上不斷變化的醫療保健標準和需求。採取積極主動的技術整合和合規性對於致力於永續成長的公司至關重要。

主要市場統計
基準年[2023] 44.4億美元
預測年份 [2024] 48.5億美元
預測年份 [2030] 85.7億美元
複合年成長率（%） 9.85%

市場動態：快速發展的靜脈輸液幫浦市場的關鍵市場洞察

供需的動態交互作用正在改變靜脈輸液幫浦市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人口老化導致慢性病盛行率上升
    • 接受手術的人數增加
    • 門診輸液幫浦需求增加
  • 市場限制因素
    • 輸液幫浦的病人安全風險和用藥錯誤
  • 市場機會
    • 擴大特殊輸液幫浦的採用
    • 輸液幫浦的技術進步
  • 市場挑戰
    • 更多採用回收輸液泵

波特五力：駕馭靜脈輸液幫浦市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解靜脈輸液幫浦市場的外部影響

外部宏觀環境因素在塑造靜脈輸液幫浦市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解靜脈輸液幫浦市場競爭格局

靜脈輸液幫浦市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣靜脈輸液幫浦市場供應商的績效評估

FPNV定位矩陣是評估靜脈輸液幫浦市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了靜脈輸液幫浦市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對靜脈輸液幫浦市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著人口老化，慢性病發生率也隨之增加
      • 接受手術的人數增加
      • 門診輸液幫浦需求增加
    • 抑制因素
      • 輸液幫浦患者安全風險與用藥錯誤
    • 機會
      • 增加採用特殊輸液泵
      • 輸液幫浦的技術進步
    • 任務
      • 更多採用回收輸液泵
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章靜脈輸液幫浦市場：依產品

  • 攜帶式輸液泵
  • 腸內輸液泵
  • 植入式輸液泵
  • 胰島素輸注泵
  • 患者自用鎮痛輸液泵
  • 注射輸液幫浦
  • 正排量輸液泵

第7章靜脈輸液幫浦市場：依疾病適應症

  • 鎮痛或疼痛管理
  • 化療
  • 糖尿病
  • 胃腸病學
  • 血液學
  • 小兒科/新生兒科

第8章美洲靜脈輸液幫浦市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太靜脈輸液幫浦市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東及非洲靜脈輸液幫浦市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Adepto Medical
  • ANGEL Electronics
  • B. Braun Melsungen AG
  • Baxter International
  • Becton, Dickinson and Company
  • Boston Scientific corporation
  • Carefusion Corporation
  • CODAN ARGUS AG
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE & Co.
  • Ivenix Inc.
  • J2S Medical
  • Medtronic Plc.
  • Micrel Medical Devices Sa
  • Pfizer Inc.
  • Shenzhen Hawk Medical Instrument Co. Ltd.
  • Smiths Medical Plc.
  • Terumo Corporation
  • Venner Medical
  • ZOLL Medical Corporation
Product Code: MRR-22146147702D

The Intravenous Infusion Pump Market was valued at USD 4.44 billion in 2023, expected to reach USD 4.85 billion in 2024, and is projected to grow at a CAGR of 9.85%, to USD 8.57 billion by 2030.

Intravenous (IV) infusion pumps are critical medical devices designed to deliver fluids, such as nutrients and medications, directly into a patient's bloodstream in controlled amounts. Their necessity arises from the need for precise administration of fluids, especially in critical care settings, to ensure optimal therapeutic outcomes and patient safety. They are widely used in healthcare facilities including hospitals, outpatient clinics, and home healthcare settings. The end-use scope spans across diverse medical domains, including oncology, gastroenterology, pediatrics, and pain management, where precise fluid administration is crucial. The growing prevalence of chronic diseases, increasing geriatric population, and technological advancements in healthcare devices are key growth factors driving the IV infusion pumps market. The latest potential opportunities in this market lie in the integration of smart technologies such as cloud computing and IoT, which enable enhanced data analytics and remote monitoring capabilities. To seize these opportunities, companies should focus on collaborative innovations with tech firms, expand R&D efforts, and enhance regulatory compliance. However, limitations such as high costs of advanced pumps, stringent regulatory requirements, and risks of technical malfunctions pose significant challenges to market growth. Additionally, the need for trained healthcare professionals to operate these devices and ensure patient safety may impede market expansion. Areas ripe for innovation include developing cost-effective infusion pumps equipped with advanced safety features, improving wireless communication capabilities, and enhancing user interface designs to reduce human error. Research into reducing device size for portability without compromising functionality could also drive market growth. The IV infusion pump market is competitive, characterized by continuous technological advancements and rigorous regulatory frameworks that necessitate constant innovation to meet evolving healthcare standards and demands. Adopting a proactive approach towards technology integration and compliance will be crucial for businesses aiming to achieve sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 4.44 billion
Estimated Year [2024] USD 4.85 billion
Forecast Year [2030] USD 8.57 billion
CAGR (%) 9.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Infusion Pump Market

The Intravenous Infusion Pump Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic diseases along with geriatric population
    • Rising number of people undergoing surgical procedures
    • Increasing demand for ambulatory infusion pumps
  • Market Restraints
    • Patient safety risk and medication errors to infusion pumps
  • Market Opportunities
    • Growing adoption of specialty infusion pumps
    • Technological advancements in infusion pumps
  • Market Challenges
    • Increasing adoption of refurbished infusion pumps

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Infusion Pump Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Infusion Pump Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Infusion Pump Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Infusion Pump Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Infusion Pump Market

A detailed market share analysis in the Intravenous Infusion Pump Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Infusion Pump Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Infusion Pump Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Infusion Pump Market

A strategic analysis of the Intravenous Infusion Pump Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Infusion Pump Market, highlighting leading vendors and their innovative profiles. These include Adepto Medical, ANGEL Electronics, B. Braun Melsungen AG, Baxter International, Becton, Dickinson and Company, Boston Scientific corporation, Carefusion Corporation, CODAN ARGUS AG, F. Hoffmann La Roche Ltd., Fresenius SE & Co., Ivenix Inc., J2S Medical, Medtronic Plc., Micrel Medical Devices Sa, Pfizer Inc., Shenzhen Hawk Medical Instrument Co. Ltd., Smiths Medical Plc., Terumo Corporation, Venner Medical, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Intravenous Infusion Pump Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Syringe Infusion Pumps, and Volumetric Infusion Pumps.
  • Based on Disease Indication, market is studied across Analgesia or Pain Management, Chemotherapy, Diabetes, Gastroenterology, Hematology, and Pediatrics & Neonatology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic diseases along with geriatric population
      • 5.1.1.2. Rising number of people undergoing surgical procedures
      • 5.1.1.3. Increasing demand for ambulatory infusion pumps
    • 5.1.2. Restraints
      • 5.1.2.1. Patient safety risk and medication errors to infusion pumps
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of specialty infusion pumps
      • 5.1.3.2. Technological advancements in infusion pumps
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing adoption of refurbished infusion pumps
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous Infusion Pump Market, by Product

  • 6.1. Introduction
  • 6.2. Ambulatory Infusion Pumps
  • 6.3. Enteral Infusion Pumps
  • 6.4. Implantable Infusion Pumps
  • 6.5. Insulin Infusion Pumps
  • 6.6. Patient-Controlled Analgesia Infusion Pumps
  • 6.7. Syringe Infusion Pumps
  • 6.8. Volumetric Infusion Pumps

7. Intravenous Infusion Pump Market, by Disease Indication

  • 7.1. Introduction
  • 7.2. Analgesia or Pain Management
  • 7.3. Chemotherapy
  • 7.4. Diabetes
  • 7.5. Gastroenterology
  • 7.6. Hematology
  • 7.7. Pediatrics & Neonatology

8. Americas Intravenous Infusion Pump Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Intravenous Infusion Pump Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Infusion Pump Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adepto Medical
  • 2. ANGEL Electronics
  • 3. B. Braun Melsungen AG
  • 4. Baxter International
  • 5. Becton, Dickinson and Company
  • 6. Boston Scientific corporation
  • 7. Carefusion Corporation
  • 8. CODAN ARGUS AG
  • 9. F. Hoffmann La Roche Ltd.
  • 10. Fresenius SE & Co.
  • 11. Ivenix Inc.
  • 12. J2S Medical
  • 13. Medtronic Plc.
  • 14. Micrel Medical Devices Sa
  • 15. Pfizer Inc.
  • 16. Shenzhen Hawk Medical Instrument Co. Ltd.
  • 17. Smiths Medical Plc.
  • 18. Terumo Corporation
  • 19. Venner Medical
  • 20. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS INFUSION PUMP MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS INFUSION PUMP MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INTRAVENOUS INFUSION PUMP MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INTRAVENOUS INFUSION PUMP MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS INFUSION PUMP MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAVENOUS INFUSION PUMP MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AMBULATORY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ENTERAL INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY IMPLANTABLE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY INSULIN INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SYRINGE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY VOLUMETRIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ANALGESIA OR PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PEDIATRICS & NEONATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. INDONESIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. INDONESIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. JAPAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. JAPAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MALAYSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MALAYSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. PHILIPPINES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. PHILIPPINES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SINGAPORE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SINGAPORE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. SOUTH KOREA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. SOUTH KOREA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. TAIWAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. TAIWAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. THAILAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. THAILAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. VIETNAM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. VIETNAM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. DENMARK INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. DENMARK INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. EGYPT INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. EGYPT INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FINLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FINLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. FRANCE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. FRANCE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. GERMANY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. GERMANY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ISRAEL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ISRAEL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. ITALY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. ITALY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NETHERLANDS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NETHERLANDS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NIGERIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NIGERIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. NORWAY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. NORWAY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. POLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. POLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. QATAR INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. QATAR INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. RUSSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. RUSSIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SPAIN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SPAIN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWEDEN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWEDEN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SWITZERLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SWITZERLAND INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. TURKEY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. TURKEY INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED ARAB EMIRATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED KINGDOM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED KINGDOM INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. INTRAVENOUS INFUSION PUMP MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 109. INTRAVENOUS INFUSION PUMP MARKET, FPNV POSITIONING MATRIX, 2023